INDP Insider Transactions
18 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–18; provenance stays internal.
INDP insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Anderson Glen R. | TenPercentOwner | 2023-08-14 | Purchase | 23,934.0 | $2.34 |
| Anderson Glen R. | TenPercentOwner | 2023-08-11 | Purchase | 35,064.0 | $2.12 |
| Anderson Glen R. | TenPercentOwner | 2023-08-10 | Purchase | 44,354.0 | $1.94 |
| Litchev Boyan Vesselinov | Chief Medical Officer | 2022-12-01 | Purchase | 500.0 | $1.87 |
| Litchev Boyan Vesselinov | Chief Medical Officer | 2022-11-22 | Purchase | 500.0 | $1.83 |
| Meckler Jeffrey A | CEO and Director | 2022-11-21 | Purchase | 9,600.0 | $1.9 |
| Meckler Jeffrey A | CEO and Director | 2022-11-18 | Purchase | 400.0 | $1.76 |
| Meckler Jeffrey A | CEO and Director | 2022-09-08 | Purchase | 10,308.0 | $2.8 |
| Linscott Walt Addison | Chief Business Officer | 2022-09-07 | Purchase | 150.0 | $2.62 |
| Meckler Jeffrey A | CEO and Director | 2022-09-07 | Purchase | 8,632.0 | $2.57 |
| Meckler Jeffrey A | CEO and Director | 2022-09-06 | Purchase | 1,060.0 | $2.44 |
| Meckler Jeffrey A | CEO and Director | 2022-06-06 | Purchase | 19,727.0 | $2.63 |
| Litchev Boyan Vesselinov | Chief Medical Officer | 2022-03-02 | Purchase | 50.0 | $4.09 |
| Newman Michael James | CSO and Director | 2022-02-01 | Sale | 14,130.0 | $5.0 |
| Litchev Boyan Vesselinov | Chief Medical Officer | 2022-01-31 | Purchase | 100.0 | $4.65 |
| Newman Michael James | CSO and Director | 2022-01-31 | Sale | 5,870.0 | $5.0 |
| Meckler Jeffrey A | CEO and Director | 2021-11-18 | Purchase | 11,187.0 | $5.82 |
| Meckler Jeffrey A | CEO and Director | 2021-09-14 | Purchase | 12,000.0 | $7.0 |